COVID-19 revisiting inflammatory pathways of arthritis

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · see citing works

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · see citing works

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016 · see citing works

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907 · see citing works

A new coronavirus associated with human respiratory disease in China

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688 · see citing works

Effective treatment of severe COVID-19 patients with tocilizumab

Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,636 · see citing works

Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology

Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524 · see citing works

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375 · see citing works

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Wichmann, D., Sperhake, J., Lütgehetmann, M., Steurer, S. A., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., Schröder, A. S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2003 · Cited by 2,271 · see citing works

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,016 · see citing works

The COVID-19 vaccine development landscape

Le, T. T., Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M. K., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,959 · see citing works

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Tan, L., Wang, Q., Zhang, D., Jinya, D., Huang, Q., Wang, Q., Wang, Q., & Miao, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0148-4 · Cited by 1,684 · see citing works

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30304-4 · Cited by 1,456 · see citing works

Middle East respiratory syndrome

Zumla, A. I., Hui, D. S. C., & Perlman, S. M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60454-8 · Cited by 1,281 · see citing works

SARS: systematic review of treatment effects

Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217 · see citing works

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation

Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191 · see citing works

SARS-CoV-2: a storm is raging

Pedersen, S. F., & Ho, Y.-C. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137647 · Cited by 1,137 · see citing works

COVID-19: combining antiviral and anti-inflammatory treatments

Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30132-8 · Cited by 1,117 · see citing works

An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics

Angelidis, I., Simon, L. M., Fernandez, I. E., Strunz, M., Mayr, C. H., Greiffo, F. R., Tsitsiridis, G., Ansari, M., Graf, E., Strom, T.-M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08831-9 · Cited by 637 · see citing works

On the Alert for Cytokine Storm: Immunopathology in COVID ‐19

Henderson, L. A., Canna, S., Schulert, G. S., Volpi, S., Lee, P. Y., Kernan, K. F., Caricchio, R., Mahmud, S. A., Hazen, M. M., Halyabar, O., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41285 · Cited by 633 · see citing works

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Wichmann, D. (2020) · Annals of Internal Medicine · doi:10.7326/l20-1206 · Cited by 630 · see citing works

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV

Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., Trilling, M., Lu, M., Dittmer, U., & Yang, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25709 · Cited by 618 · see citing works

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Feldmann, M., Maini, R. N., Woody, J. N., Holgate, S. T., Winter, G., Rowland, M. J., Richards, D. B., & Hussell, T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30858-8 · Cited by 531 · see citing works

Middle East Respiratory Syndrome

Arabi, Y. M., Balkhy, H. H., Hayden, F. G., Bouchama, A., Luke, T., Baillie, J. K., Al-Omari, A., Hajeer, A. H., Senga, M., Denison, M. R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmsr1408795 · Cited by 518 · see citing works

Kawasaki-like disease: emerging complication during the COVID-19 pandemic

Viner, R., & Whittaker, E. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31129-6 · Cited by 503 · see citing works

The Role of Interleukin 6 During Viral Infections

Velázquez-Salinas, L., Verdugo-Rodríguez, A., Rodriguez, L. L., & Borca, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01057 · Cited by 488 · see citing works

Middle East respiratory syndrome

Memish, Z. A., Perlman, S. M., Kerkhove, M. D. V., & Zumla, A. I. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33221-0 · Cited by 484 · see citing works

Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells

Law, H., Cheung, C. Y., Ng, H. Y., Sia, S. F., Chan, Y. O., Luk, W., Nicholls, J. M., Peiris, M. J. S., & Lau, Y. (2005) · Blood · doi:10.1182/blood-2004-10-4166 · Cited by 467 · see citing works

COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Sarzi‐Puttini, P., Giorgi, V., Sirotti, S., Marotto, D., Ardizzone, S., Rizzardini, G., Antinori, S., & Galli, M. (2020) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/xcdary · Cited by 464 · see citing works

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

Monti, S. M., Balduzzi, S., Delvino, P., Bellis, E., Quadrelli, V. S., & Montecucco, C. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217424 · Cited by 445 · see citing works

Clinical presentations and outcome of severe acute respiratory syndrome in children

Hon, K., Leung, C., Cheng, W., Chan, P., Chu, C. W., Kwan, M. Y. W., Li, A., Fong, N., Ng, P., Chiu, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13364-8 · Cited by 388 · see citing works

COVID-19: risk for cytokine targeting in chronic inflammatory diseases?

Schett, G. A., Sticherling, M., & Neurath, M. F. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0312-7 · Cited by 349 · see citing works

Innate Immune Response of Human Alveolar Type II Cells Infected with Severe Acute Respiratory Syndrome–Coronavirus

Qian, Z., Travanty, E. A., Oko, L. M., Edeen, K. E., Berglund, A., Wang, J., Ito, Y., Holmes, K. V., & Mason, R. J. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0339oc · Cited by 314 · see citing works

Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus

Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S., & Katze, M. G. (2013) · mBio · doi:10.1128/mbio.00165-13 · Cited by 298 · see citing works

Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells

Yoshikawa, T., Hill, T. E., Li, K., Peters, C. J., & Tseng, C.-T. K. (2008) · Journal of Virology · doi:10.1128/jvi.01792-08 · Cited by 291 · see citing works

A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis

Bechman, K., Subesinghe, S., Norton, S., Atzeni, F., Galli, M., Cope, A. P., Winthrop, K. L., & Galloway, J. B. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez087 · Cited by 286 · see citing works

Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells

Rauber, S., Luber, M., Weber, S., Maul, L., Soare, A., Wohlfahrt, T., Lin, N., Dietel, K., Bözec, A., i, M. H., et al. (2017) · Nature Medicine · doi:10.1038/nm.4373 · Cited by 283 · see citing works

Severe Acute Respiratory Syndrome

Christian, M. D., Poutanen, S. M., Loutfy, M. R., Muller, M. P., & Low, D. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420743 · Cited by 224 · see citing works

Baricitinib for COVID-19: a suitable treatment?

Favalli, E. G., Biggioggero, M., Maioli, G., & Caporali, R. F. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30262-0 · Cited by 213 · see citing works

Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study

Blumentals, W. A., Arreglado, A., Napalkov, P., & Toovey, S. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-158 · Cited by 159 · see citing works

IL-1 and TNFα Contribute to the Inflammatory Niche to Enhance Alveolar Regeneration

Katsura, H., Kobayashi, Y., Tata, P. R., & Hogan, B. L. M. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.02.013 · Cited by 158 · see citing works

Th2 and eosinophil responses suppress inflammatory arthritis

Zhu, C., Andreev, D., Oeser, K., Krljanac, B., Hueber, A. J., Kleyer, A., Voehringer, D., Schett, G. A., & Bözec, A. (2016) · Nature Communications · doi:10.1038/ncomms11596 · Cited by 151 · see citing works

Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy

Norsa, L., Indriolo, A., Sansotta, N., Cosimo, P., Greco, S., & D’Antiga, L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.062 · Cited by 149 · see citing works

Viral arthritis

Marks, M., & Marks, J. L. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-2-129 · Cited by 142 · see citing works

Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-κB

Zhang, X., Wu, K., Wang, D., Yue, X., Song, D., Zhu, Y., & Wu, J. (2007) · Virology · doi:10.1016/j.virol.2007.04.009 · Cited by 141 · see citing works

Respiratory viral infections and the risk of rheumatoid arthritis

Joo, Y. B., Lim, Y.-H., Kim, K., Park, K., & Park, Y. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1977-9 · Cited by 136 · see citing works

Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists

Fleming, S. B. (2016) · Vaccines · doi:10.3390/vaccines4030023 · Cited by 120 · see citing works

Middle East Respiratory Syndrome

Shalhoub, S., Memish, Z. A., & Arabi, Y. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-54841-0.00004-4 · Cited by 113 · see citing works

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1

Friedman, N., Alter, H., Hindiyeh, M. Y., Mendelson, E., Avni, Y. S., & Mandelboim, M. (2018) · Viruses · doi:10.3390/v10100515 · Cited by 102 · see citing works

Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19

Praveen, D., Puvvada, R. C., & Aanandhi, M. V. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105967 · Cited by 96 · see citing works

IL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human Cells

Ryzhakov, G., Lai, C., Blazek, K. D., To, K.-W., Hussell, T., & Udalova, I. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100917 · Cited by 91 · see citing works

Age-Associated Increase in Cytokine Production During Systemic Inflammation—II: The Role of IL-1β in Age-Dependent IL-6 Upregulation in Adipose Tissue

Starr, M. E., Saito, M., Evers, B. M., & Saitō, H. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu197 · Cited by 90 · see citing works

Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs.

Meroni, P. L., Zavaglia, D., & Girmenia, C. (2018) · PubMed · Cited by 56 · see citing works

Symptom Combinations Associated with Outcome and Therapeutic Effects in a Cohort of Cases with SARS

Li, S., Wang, R., Zhang, Y., Zhang, X., Layon, A. J., Li, Y., & Chen, M. (2006) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x06004417 · Cited by 54 · see citing works

Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice

Pedersen, K. B., Chodavarapu, H., Porretta, C. P., Robinson, L. K., & Lazartigues, E. D. (2015) · Endocrinology · doi:10.1210/en.2015-1556 · Cited by 50 · see citing works

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic

Spinelli, F. R., Ceccarelli, F., Franco, M. D., & Conti, F. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217367 · Cited by 49 · see citing works

TNF-α inhibition for potential therapeutic modulation of SARS coronavirus infection

Tobinick, E. L. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125002757 · Cited by 48 · see citing works

Protection of 318 Inflammatory Bowel Disease Patients from the Outbreak and Rapid Spread of COVID-19 Infection in Wuhan, ChinaPreprint

An, P., Ji, M., Ren, H., Su, J., Kang, J., Yin, A., Zhou, Q., Shen, L., Zhao, L., Jiang, X., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3543590 · Cited by 48 · see citing works

The Transition from Reimagining to Recreating Health Care Is Now

HollanderJudd, E., & SitesFrank, D. (2020) · NEJM Catalyst · Cited by 42 · see citing works

What is the role of rheumatologists in the era of COVID-19?

Marotto, D., & Sarzi‐Puttini, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102539 · Cited by 30 · see citing works

How to approach and treat viral infections in ICU patients

Kelesidis, T., Mastoris, I., Metsini, A., & Tsiodras, S. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-321 · Cited by 28 · see citing works

N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4+ T cells

Housseau, F., Moorthy, A., Langer, D., Robbins, P. F., Gonzales, M. I., & Topalian, S. L. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200109)31:9 · Cited by 20 · see citing works

On the Alert for Cytokine Storm: Immunopathology in COVID ‐19

Henderson, L. A., Canna, S., Schulert, G. S., Volpi, S., Lee, P. Y., Kernan, K. F., Caricchio, R., Mahmud, S. A., Hazen, M. M., Halyabar, O., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41285 · Cited by 633 · see citing works

Kawasaki-like disease: emerging complication during the COVID-19 pandemic

Viner, R., & Whittaker, E. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31129-6 · Cited by 503 · see citing works

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

Geisen, U. M., Berner, D. K., Tran, F., Sümbül, M., Vullriede, L., Ciripoi, M., Reid, H. M., Schaffarzyk, A., Longardt, A. C., Franzenburg, J., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220272 · Cited by 355 · see citing works

The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options

Choudhary, S., Sharma, K., & Silakari, O. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104673 · Cited by 210 · see citing works

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies

Raman, R., Patel, K. J., & Ranjan, K. (2021) · Biomolecules · doi:10.3390/biom11070993 · Cited by 186 · see citing works

Point-of-care COVID-19 diagnostics powered by lateral flow assay

Zhou, Y., Wu, Y., Ding, L., Huang, X., & Xiong, Y. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116452 · Cited by 182 · see citing works

A review of cytokine-based pathophysiology of Long COVID symptoms

Low, R. N., Low, R. J., & Akrami, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1011936 · Cited by 196 · see citing works

Viral Infections, the Microbiome, and Probiotics

Harper, A., Vijayakumar, V., Ouwehand, A. C., ter Haar, J., Obis, D., Espadaler, J., Binda, S., Desiraju, S., & Day, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.596166 · Cited by 177 · see citing works

Musculoskeletal involvement of COVID-19: review of imaging

Ramani, S. L., Samet, J. D., Franz, C. K., Hsieh, C., Nguyen, C. V., Horbinski, C., & Deshmukh, S. D. (2021) · Skeletal Radiology · doi:10.1007/s00256-021-03734-7 · Cited by 139 · see citing works

The role of Interleukin 6 inhibitors in therapy of severe COVID-19

Nasonov, E. L., & MIu, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110698 · Cited by 124 · see citing works

Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19

Tüzün, Ş., Keles, A., Okutan, D., Yildiran, T., & Palamar, D. (2021) · European Journal of Physical and Rehabilitation Medicine · doi:10.23736/s1973-9087.20.06563-6 · Cited by 114 · see citing works

The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals

Cañas, C. A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110345 · Cited by 112 · see citing works

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19

Peter, A. E., Sandeep, B. V., Rao, B. G., & Kalpana, V. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.583777 · Cited by 99 · see citing works

Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral–bacterial interactions

Kruglikov, I. L., Shah, M., & Scherer, P. E. (2020) · eLife · doi:10.7554/elife.61330 · Cited by 98 · see citing works

AI-enabled remote monitoring of vital signs for COVID-19: methods, prospects and challenges

Rohmetra, H., Raghunath, N., Narang, P., Chamola, V., Guizani, M., & Lakkaniga, N. R. (2021) · Computing · doi:10.1007/s00607-021-00937-7 · Cited by 95 · see citing works

Vitamin D deficiency: concern for rheumatoid arthritis and COVID-19?

Verma, S., Chaturvedi, V. P., Ganguly, N. K., & Mittal, S. A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04245-8 · Cited by 87 · see citing works

Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management

Savla, S. R., Prabhavalkar, K. S., & Bhatt, L. K. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1915129 · Cited by 88 · see citing works

Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses

Rabaan, A. A., Al-Ahmed, S. H., Garout, M. A., Al‐Qaaneh, A. M., Sule, A. A., Tirupathi, R., Mutair, A. S. A., Alhumaid, S., Hasan, A., Dhawan, M. K., et al. (2021) · Pathogens · doi:10.3390/pathogens10050565 · Cited by 84 · see citing works

The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities

Alyammahi, S. K., Abdin, S. M., Alhamad, D. W., Elgendy, S. M., Altell, A. T., & Omar, H. A. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104647 · Cited by 83 · see citing works

A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection

Jamison, D. A., Narayanan, S. A., Trovão, N. S., Guarnieri, J. W., Topper, M. J., Moraes‐Vieira, P. M., Zaksas, V., Singh, K. K., Wurtele, E. S., & Beheshti, A. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01108-8 · Cited by 81 · see citing works

Treatment of MIS-C in Children and Adolescents

Mahmoud, S. A., El-Kalliny, M. M., Kotby, A., El-Ganzoury, M. M., Fouda, E. M., & Ibrahim, H. M. (2022) · Current Pediatrics Reports · doi:10.1007/s40124-021-00259-4 · Cited by 77 · see citing works

Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic

Ahmed, S., Gasparyan, A. Y., & Zimba, O. (2021) · Rheumatology International · doi:10.1007/s00296-020-04764-5 · Cited by 73 · see citing works

EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection

Chourasia, M., Koppula, P. R., Battu, A., Ouseph, M. M., & Singh, A. (2021) · Molecules · doi:10.3390/molecules26051200 · Cited by 73 · see citing works

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges

Dewanjee, S., Kandimalla, R. J. L., Kalra, R. S., Valupadas, C., Vallamkondu, J., Kolli, V., Ray, S. D., Reddy, A. P., & Reddy, P. H. (2021) · Cells · doi:10.3390/cells10123291 · Cited by 70 · see citing works

Pay attention to doctor–patient dialogues: Multi-modal knowledge graph attention image-text embedding for COVID-19 diagnosis

Zheng, W., Yan, L., Gou, C., Zhang, Z.-C., Zhang, J. J., Hu, M., & Wang, F. (2021) · Information Fusion · doi:10.1016/j.inffus.2021.05.015 · Cited by 60 · see citing works

Graphene‐based Materials for Fighting Coronavirus Disease 2019: Challenges and Opportunities

Maqbool, I., Rehman, F., Soomro, F., Bhatti, Z., Ali, U., Jatoi, A. H., Lal, B., Iqbal, M., Phulpoto, S., Ali, A., et al. (2021) · ChemBioEng Reviews · doi:10.1002/cben.202000039 · Cited by 60 · see citing works

Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank

Topless, R., Phipps‐Green, A. J., Leask, M., Dalbeth, N., Stamp, L. K., Robinson, P. C., & Merriman, T. R. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11252 · Cited by 55 · see citing works

Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia

Nasonov, E. L., Lila, A. M., Vi, M., Belov, B. S., Karateev, A. E., Дубинина, Т. В., Nikitinskaya, O. A., Baranov, A. A., Abdulganieva, D. I., Moiseev, S. V., et al. (2021) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2021-239-254 · Cited by 54 · see citing works

Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies

Han, N., Hwang, W., Tzelepis, K., Schmerer, P., Yankova, E., MacMahon, M., Lei, W., Katritsis, N. M., Liu, A., Felgenhauer, U., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh3032 · Cited by 51 · see citing works

A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management

Bansal, N., Pasricha, C., Kumari, P., Jangra, S., Kaur, R., & Singh, R. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103337 · Cited by 49 · see citing works

Pain as clinical manifestations of COVID-19 infection and its management in the pandemic era: a literature review

Widyadharma, I. P. E., Sari, N. N. S. P., Pradnyaswari, K. E., Yuwana, K. T., Adikarya, I. P. G. D., Tertia, C., Wijayanti, I. A. S., Indrayani, I. A. S., & Utami, D. K. I. (2020) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-020-00258-0 · Cited by 43 · see citing works

Predictors of Long COVID in Patients without Comorbidities: Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study

Chudzik, M., Lewek, J., Kapusta, J., Banach, M., Jankowski, P., & Bielecka-Dabrowa, A. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11174980 · Cited by 39 · see citing works

COVID-19: An Emerging Culprit of Inflammatory Arthritis

Mukarram, M. S., Ghauri, M. I., Sethar, S., Afsar, N. A., Riaz, A., & Ishaq, K. (2021) · Case Reports in Rheumatology · doi:10.1155/2021/6610340 · Cited by 39 · see citing works

Coronavirus disease 2019 (COVID-19) and autoimmunity

Nasonov, E. L. (2021) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2021-5-30 · Cited by 40 · see citing works

IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA

Zheng, Q., Wang, D., Lin, R., Lv, Q., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013322 · Cited by 37 · see citing works

COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia

Khodeir, M. M., Shabana, H. A., Rasheed, Z., Alkhamiss, A. S., Khodeir, M., Alkhowailed, M. S., Alharbi, S., Alsoghair, M., Alsagaby, S. A., & Abdulmonem, W. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260259 · Cited by 36 · see citing works

Hidden link in gut–joint axis: gut microbes promote rheumatoid arthritis at early stage by enhancing ascorbate degradation

Zhao, Y., Cheng, M., Zou, L., Yin, L., Zhong, C., Zha, Y., Zhu, X. H., Zhang, L., Ning, K., & Han, J. (2021) · Gut · doi:10.1136/gutjnl-2021-325209 · Cited by 36 · see citing works

Is post-COVID syndrome an autoimmune disease?

Anaya, J., Herrán, M., Beltrán, S., & Rojas, M. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2085561 · Cited by 36 · see citing works

A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?

Shakaib, B., Zohra, T., Ikram, A., Shakaib, M. B., Ali, A. A. A., Bashir, A., Salman, M., Khan, M. A., & Ansari, J. A. (2021) · Virology Journal · doi:10.1186/s12985-021-01578-0 · Cited by 33 · see citing works

Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?

Fialho, M. F. P., Brum, E. S., & Oliveira, S. M. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01160-w · Cited by 33 · see citing works

Computational insight of dexamethasone against potential targets of SARS-CoV-2

Fadaka, A. O., Sibuyi, N. R. S., Madiehe, A. M., & Meyer, M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1819880 · Cited by 33 · see citing works

Inflammatory arthritis in patients with COVID-19

Conway, R. P., Konig, M. F., Graef, E. R., Webb, K., Yazdany, J., & Kim, A. H. J. (2021) · Translational research · doi:10.1016/j.trsl.2021.02.010 · Cited by 32 · see citing works

COVID-19 illness and autoimmune diseases: recent insights

Li, J., Liu, H., Yin, X., Li, C., & Wang, J. (2021) · Inflammation Research · doi:10.1007/s00011-021-01446-1 · Cited by 32 · see citing works

COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon

Hasselbalch, H. C., Skov, V., Kjær, L., Ellervik, C., Poulsen, A., Poulsen, T. D., & Nielsen, C. H. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.03.006 · Cited by 29 · see citing works

Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature

Colatutto, D., Sonaglia, A., Zabotti, A., Cereser, L., Girometti, R., & Quartuccio, L. (2021) · Viruses · doi:10.3390/v13081558 · Cited by 29 · see citing works

A case report of monoarthritis in a COVID-19 patient and literature review

Cincinelli, G., Taranto, R. D., Orsini, F., Rindone, A., Murgo, A., & Caporali, R. F. (2021) · Medicine · doi:10.1097/md.0000000000026089 · Cited by 27 · see citing works

Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19

Wang, L., Wang, Y., Yang, W., He, X., Xu, S., Liu, X., He, Y., Hu, Q. Y., Yuan, D., & Jin, T. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001374 · Cited by 25 · see citing works

Bioinformatics and System Biology Approach to Identify the Influences of COVID-19 on Rheumatoid Arthritis

Hu, H., Tang, N., Zhang, F., Li, L., & Li, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.860676 · Cited by 25 · see citing works

Macrophage Reprogramming via Targeted ROS Scavenging and COX-2 Downregulation for Alleviating Inflammation

Luo, X., Xiong, H., Jiang, Y., Fan, Y., Zuo, C., Chen, D., Chen, L., Lin, H., & Gao, J. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00239 · Cited by 25 · see citing works

Inspiration for COVID-19 Treatment: Network Analysis and Experimental Validation of Baicalin for Cytokine Storm

You, J., Li, H., Fan, P., Yang, X., Wei, Y., Zheng, L., Li, Z. S., & Cheng, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.853496 · Cited by 23 · see citing works

Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions

Nain, Z., BARMAN, S. K., Sheam, M. M., Syed, S. B., Samad, A., Quinn, J. M. W., Karim, M. M., Himel, M. K., Roy, R. K., Moni, M. A., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab197 · Cited by 23 · see citing works

Heterocellular N-cadherin junctions enable nontransformed cells to inhibit the growth of adjacent transformed cells

Sheehan, S. A., Hamilton, K. L., Retzbach, E. P., Balachandran, P., Krishnan, H., Leone, P., & Goldberg, G. S. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-021-00817-9 · Cited by 22 · see citing works

COVID-19-associated arthritis: an emerging new entity?

Farisoğulları, B., Pinto, A. S., & Machado, P. (2022) · RMD Open · doi:10.1136/rmdopen-2021-002026 · Cited by 22 · see citing works

Classical and Counter-Regulatory Renin–Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology

Almutlaq, M., Alamro, A. A., Alroqi, F. J., & Barhoumi, T. (2021) · CJC Open · doi:10.1016/j.cjco.2021.04.004 · Cited by 22 · see citing works

Impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection and disease-2019 (COVID-19) on the quality of life of rheumatoid arthritis patients in Benin

Zomalheto, Z. C., Assogba, C., & Dossou-yovo, H. (2020) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2020.07.001 · Cited by 21 · see citing works

Pattern Recognition Proteins: First Line of Defense Against Coronaviruses

Labarrere, C. A., & Kassab, G. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652252 · Cited by 21 · see citing works

The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy

Wang, Y., Wu, M., Li, Y., Yuen, H. H., & He, M. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00811-4 · Cited by 22 · see citing works

Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease

Zhang, W., Liu, L., Xiao, X., Zhou, H., Peng, Z., Wang, W., Huang, L., Xie, Y., Xu, H., Tao, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.961642 · Cited by 20 · see citing works

Inflammatory Arthritis After COVID-19: A Case Series

Yadav, S., Bonnes, S. L. R., Gilman, E. A., Mueller, M. R., Collins, N. M., Hurt, R. T., & Ganesh, R. (2023) · American Journal of Case Reports · doi:10.12659/ajcr.939870 · Cited by 19 · see citing works

Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review

Peddapalli, A., Gehani, M., Kalle, A. M., Peddapalli, S. R., Peter, A. E., & Sharad, S. (2021) · Viruses · doi:10.3390/v13030378 · Cited by 19 · see citing works

Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression

Sheehan, S. A., Hamilton, K. L., Retzbach, E. P., Balachandran, P., Krishnan, H., Leone, P., López-González, M., Suryavanshi, S., Kumar, P., Russo, R., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112594 · Cited by 18 · see citing works

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

Chaudhry, Z. S., Nellessen, N., Reis, C., & Sharip, A. (2022) · Family Practice · doi:10.1093/fampra/cmac029 · Cited by 18 · see citing works

Serum amyloid A—A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19

Almusalami, E. M., Lockett, A., Ferro, A., & Posner, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1135695 · Cited by 18 · see citing works

A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management

Shoaib, M. H., Ahmed, F. R., Sikandar, M., Yousuf, R. I., & Saleem, M. T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.576448 · Cited by 18 · see citing works

COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease

Kondo, Y., Kaneko, Y., Takei, H., Tamai, H., Kabata, H., Suhara, T., Yamamoto, R., Nagata, H., Ishii, M., Sasaki, J., et al. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/44kaji · Cited by 18 · see citing works

COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs

Tsai, J., Liu, L., Chen, C., Chen, L., Wang, S., & Wei, J. C.-C. (2023) · RMD Open · doi:10.1136/rmdopen-2023-003038 · Cited by 18 · see citing works

Metabolomic profiling of threeAraucariaspecies, and their possible potential role against COVID-19

El‐Hawary, S. S., Rabeh, M. A., Raey, M. A. E., El-Kader, E. M. A., Sobeh, M., Abdelmohsen, U. R., Albohy, A., Andrianov, A. M., Bosko, I. P., Al-Sanea, M. M., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1885494 · Cited by 17 · see citing works

Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China

Qi, G.-Y., Wang, H., Guo, Y., Peng, C., Zhang, C., Chen, T., He, J., & Jin, Z. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06086-2 · Cited by 16 · see citing works

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19

Liang, H., Wu, Y., Yau, V., Yin, H.-X., Lowe, S., Bentley, R., Ahmed, M. A., Zhao, W., & Sun, C. (2022) · Vaccines · doi:10.3390/vaccines10091538 · Cited by 16 · see citing works

Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival

Cao, J., Gong, Y., Wu, M., Xiong, L., Chen, S., Huang, H., Zhou, X., Ying-chun, P., Shen, X., Qu, J., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1044770 · Cited by 16 · see citing works

Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study

Bryushkova, E. A., Skatova, V. D., Mutovina, Z. Y., Игоревна, З. А., Fomina, D. S., Kruglova, T. S., Akopyan, A. A., Strazhesko, I. D., Lukyanov, S., Ткачева, О. Н., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273340 · Cited by 15 · see citing works

Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?

Hasseli, R., Pfeil, A., Hoyer, B. F., Krause, A., Lorenz, H., Richter, J., Schmeiser, T., Voll, R. E., Schulze‐Koops, H., Specker, C., et al. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/1bq5pl · Cited by 15 · see citing works

Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis

Peng, J., She, X., Mei, H., Zheng, H., Fu, M., Liang, G., Wang, Q., & Liu, W. (2022) · Aging · doi:10.18632/aging.203834 · Cited by 15 · see citing works

Coronavirus Infection 2019 (COVID-19) and Autoimmunity

Nasonov, E. L., Samsonov, M. Y., & Lila, A. M. (2022) · Herald of the Russian Academy of Sciences · doi:10.1134/s1019331622040062 · Cited by 14 · see citing works

Surgically treated reactive arthritis of the ankle after COVID-19 infection: A case report

Shimoyama, K., Teramoto, A., Murahashi, Y., Takahashi, K., Watanabe, K., Iba, K., & Yamashita, T. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2021.12.028 · Cited by 14 · see citing works

A Cytokine-based model for the pathophysiology of Long COVID symptomsPreprint

Low, R. N., Low, R. J., & Akrami, A. (2020) · doi:10.31219/osf.io/7gcnv · Cited by 14 · see citing works

Evaluation of post-COVID health status using the EuroQol-5D-5L scale

Hegde, S., Sreeram, S., Bhat, K. R., Satish, V., Shekar, S., & Babu, M. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2035623 · Cited by 13 · see citing works

Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities

Napodano, C., Pocino, K., Gulli, F., Rossi, E. G., Rapaccini, G. L., Marino, M., & Basile, U. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.08.002 · Cited by 13 · see citing works

Assessment of risk factors in post- COVID-19 patients and its associated musculoskeletal manifestations: A cross-sectional study in India

Jeyaraman, M., Selvaraj, P., Jeyaraman, N., Prajwal, G. S., & Muthu, S. (2022) · Journal of Orthopaedics · doi:10.1016/j.jor.2022.07.011 · Cited by 13 · see citing works

Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection

Bahari, Z., Jangravi, Z., Ghoshooni, H., Afarinesh, M. R., & Meftahi, G. H. (2021) · Inflammation Research · doi:10.1007/s00011-021-01445-2 · Cited by 13 · see citing works

Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects

Nasonov, E. L. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2024-32-54 · Cited by 12 · see citing works

Progress on diagnosis and treatment of multisystem inflammatory syndrome in children

Peng, Z., & Zhou, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551122 · Cited by 12 · see citing works

Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology

Nasonov, E. L., & Korotaeva, T. V. (2022) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2022-131-148 · Cited by 12 · see citing works

Chronic arthritis related to SARS-CoV-2 infection in a pediatric patient: A case report

Crivelenti, L. R. D. M. P., Frazão, M. M. N., Maia, M. P. D. M., Gomes, F. H. R., & de Carvalho, L. M. (2021) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2021.101585 · Cited by 11 · see citing works

Genetic susceptibility to autoimmunity—Current status and challenges

Huang, M., & Xu, H. (2022) · Advances in immunology · doi:10.1016/bs.ai.2022.08.004 · Cited by 11 · see citing works

Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’

Valor, L., Taşçılar, K., Simón, D., Distler, J. H. W., Kleyer, A., Schett, G. A., & Rech, J. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220898 · Cited by 11 · see citing works

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging association, therapeutic options, and challengesPreprint

Kandimalla, R. J. L., Dewanjee, S., Kalra, R. S., Valupadas, C., Vallamkondu, J., Kolli, V., Reddy, P. A., & Reddy, P. H. (2021) · doi:10.31219/osf.io/pzehv · Cited by 11 · see citing works

COVID-19-induced psoriatic arthritis: a case report

Essien, F. A., Chastant, L., McNulty, C., Hubbard, M., Lynette, L., & Carroll, M. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221099333 · Cited by 10 · see citing works

Pathogenic role of cytokines in COVID-19, its association with contributing co-morbidities and possible therapeutic regimens

Tanveer, A., Akhtar, B., Sharif, A., Saleem, U., Rasul, A., Ahmad, A., & Jilani, K. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01040-9 · Cited by 10 · see citing works

Knowledge and Perceptions of Reactive Arthritis Diagnosis and Management Among Healthcare Workers During the COVID-19 Pandemic: Online Survey

Bekaryssova, D., Joshi, M. M., Gupta, L., Yessirkepov, M., Gupta, P., Zimba, O., Gasparyan, A. Y., Ahmed, S., Kitas, G. D., & Agarwal, V. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e355 · Cited by 10 · see citing works

Treatment of multisystem inflammatory syndrome in children

Tong, T., Jin, Y.-H., Wang, M., & Gong, F. (2024) · World Journal of Pediatrics · doi:10.1007/s12519-024-00798-y · Cited by 10 · see citing works

Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents

Costagliola, G., Spada, E., & Consolini, R. (2021) · Pediatric Rheumatology · doi:10.1186/s12969-021-00559-5 · Cited by 10 · see citing works

Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19

Schumann, S., Kaiser, A., Nicoletti, F., Mangano, K., Fagone, P., van Wijk, E., Yan, Y., Schulz, P. M., Ludescher, B., Niedermaier, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228803 · Cited by 9 · see citing works

Rheumatic Symptoms Following Coronavirus Disease 2019 (COVID-19): A Chronic Post–COVID-19 Condition

Cui, D., Wang, Y., Huang, L., Gu, X., Huang, Z., Mu, S., Wang, C., & Cao, B. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac170 · Cited by 9 · see citing works

COVID-19 and rheumatic diseases: A mini-review

Roseti, L., & Grigolo, B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.997876 · Cited by 10 · see citing works

Bone Mineral Density, Bone Biomarkers, and Joints in Acute, Post, and Long COVID-19: A Systematic Review

Alghamdi, F., Mokbel, K., Meertens, R. M., Obotiba, A. D., Alharbi, M., KNAPP, K. M., & Strain, W. D. (2024) · Viruses · doi:10.3390/v16111694 · Cited by 9 · see citing works

2019 Coronavirus disease (COVID-19): contribution of rheumatology

Nasonov, E. L. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.05.200799 · Cited by 8 · see citing works

Remdesivir Use and Controversies in COVID-19 Pneumonia: Myths and Reality!

Patil, S. V., Mugalikar, A., Patil, D., & Gondhali, G. (2022) · Journal of Translational Critical Care Medicine · doi:10.4103/jtccm-d-22-00010 · Cited by 8 · see citing works

The Musculoskeletal Manifestations of COVID-19: A Narrative Review Article

Alexander, A. J., Joshi, A., & Mehendale, A. M. (2022) · Cureus · doi:10.7759/cureus.29076 · Cited by 8 · see citing works

The Potential of Exerkines in Women’s COVID-19: A New Idea for a Better and More Accurate Understanding of the Mechanisms behind Physical Exercise

Suzuki, K., Hekmatikar, A. H. A., Jalalian, S., Abbasi, S., Ahmadi, E., Kazemi, A., Ruhee, R. T., & Khoramipour, K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315645 · Cited by 8 · see citing works

The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches

Xiao, J., Liang, C., Zhang, L., Li, J., & Liu, S.-J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0406

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging association, therapeutic options, and challengesPreprint

Kandimalla, R. J. L., Dewanjee, S., Kalra, R. S., Valupadas, C., Vallamkondu, J., Kolli, V., Reddy, P. A., & Reddy, P. H. (2021) · doi:10.31219/osf.io/pzehv · Cited by 11 · see citing works

Study of the Worsening of Rheumatoid Arthritis After Sars-Cov2 Infection

de Assis, L. S., Paschoal, J. F. B., Bezerra, T. A. R., & Silva, P. A. R. (2024) · International Journal of Research Publication and Reviews · doi:10.55248/gengpi.5.0224.0431

COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies

Elemam, N. M., Maghazachi, A. A., & Hannawi, S. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1906637 · Cited by 18 · see citing works

Arthritis after SARS-CoV-2 infection

Baimukhamedov, C., Barskova, T., & Matucci‐Cerinic, M. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00067-9 · Cited by 57 · see citing works